Dr. Francois Rousseau
François Rousseau MD, MSc, FRCPC
Department of Molecular Biology
Medical Biochemistry and Pathology
Dr. François Rousseau is a medical biochemist subspecialized in molecular genetics. He is a Professor in the Department of Molecular Biology, Medical Biochemistry and Pathology at the Faculty of Medicine, Université Laval. He leads a clinical research team at the Unité de recherche en génétique humaine et moléculaire, Centre de recherche du CHU de Québec – Hôpital Saint-François d’Assise. He also heads the Department of Medical Biology of the Québec University Hospital Centre. Dr. Rousseau holds a FRQS/MSSS Chair in Health Technology Assessment and Evidence Based Laboratory Medicine.
Dr. Rousseau obtained a BSc in medicine (1983), a MD in medicine (1984) and a MSc in Molecular Ontogeny (1987), all from Université Laval. He completed a post-doctoral fellowship in Human Molecular Genetics at Université Louis-Pasteur in Strasbourg (1991), where he was part of a research team that discovered the gene for fragile-X syndrome, an inherited disease causing intellectual disabilities in men. His work focuses on the translation of discoveries stemming from the Human Genome Project in the health care system.
Funded by the Canadian Institutes for Health Research (CIHR) since 1992, he realized large molecular epidemiology studies allowing for the discovery of new biomarkers for bone density. From 2003 to 2009 he chaired the International Federation of Clinical Chemistry and Laboratory Medicine committee on molecular diagnostics. Within the Québec Health Technology Assessment Agency, he was a member of the experts committee on genetic testing and is now a member of the experts committee on diagnostic tests. Dr. Rousseau also co-chaired the Internal Advisory Board of the CIHR Institute of Genetics (2000-2005).
Dr. Rousseau is a member of the Scientific Advisory Board of the Canadian Cochrane Network. He is the designated principal investigator of the CIHR-funded Canadian APOGEE-Net/CanGeneTest research consortium on health services research in genetics that focuses on transferring clinically useful and cost-effective genetic innovations to the health care system. He is also a Fellow of the Royal College of Physicians and Surgeons of Canada in medical biochemistry and has published several articles in many prestigious journals.